Home > Insider Trading > Filing (0001493152-24-036104)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1710340	Eton Pharmaceuticals Inc.	ETON	()	MA

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1595855	Opaleye Management Inc.	One Boston Place, 26Th Floor Boston MA 02108		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	Acquisiton	2024-09-10	50,000	$4.65	2,660,000	No	4	P	Indirect	By Opaleye, L.P.
Common Stock, Par Value $0.001 Per Share	Acquisiton	2024-09-10	7,500	$4.65	70,000	No	4	P	Indirect	By Managed account
Common Stock, Par Value $0.001 Per Share	Acquisiton	2024-09-11	45,000	$4.75	2,705,000	No	4	P	Indirect	By Opaleye, L.P.
Common Stock, Par Value $0.001 Per Share	Acquisiton	2024-09-11	5,000	$4.75	75,000	No	4	P	Indirect	By Managed account

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Opaleye, L.P.
No	4	P	Indirect	By Managed account
No	4	P	Indirect	By Opaleye, L.P.
No	4	P	Indirect	By Managed account

Footnotes

Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.
Opaleye Management Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Opaleye Management Inc. is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose.